X-Gen Pharmaceuticals Inc. recalls Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Singl…
- Recall date
- February 8, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0637-2017
- FDA classification
- Class I
- Brand / firm
- X-Gen Pharmaceuticals Inc.
- Sold / distributed
- Nationwide in the USA.
Why it was recalled
Presence of Particulate Matter
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Single-Dose Vials per carton (NDC 39822-1030-2); Rx only, Distributed by: X-Gen Pharmaceuticals, Inc., Big Flats, NY 14814; Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645.
Get recall alerts
Free email alert whenever X-Gen Pharmaceuticals Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: X-Gen Pharmaceuticals Inc.